BOOTHBAY FUND MANAGEMENT, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$230,000
-3.8%
34,379
+22.8%
0.01%
-25.0%
Q2 2021$239,000
+58.3%
27,999
+63.8%
0.01%
+33.3%
Q1 2021$151,000
-51.0%
17,095
-54.8%
0.01%
-68.4%
Q3 2020$308,000
+163.2%
37,848
+209.7%
0.02%
+137.5%
Q2 2020$117,000
+39.3%
12,220
-1.5%
0.01%
+14.3%
Q1 2020$84,000
-82.0%
12,400
-73.0%
0.01%
-89.7%
Q4 2018$466,000
+91.8%
45,863
+130.0%
0.07%
+223.8%
Q2 2018$243,00019,9440.02%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders